Idosos com síndrome demencial usuários de Cannabis sativa – indicadores de qualidade de vida: uma revisão integrativa da literatura.

Abstract

The increase in the elderly population worldwide has been projected, as well as the incidence and prevalence of diseases related to this age group. The objective of this study was to verify the effectiveness of cannabis therapy on dementia syndrome, showing which factors contribute to the choice of treatment, exposing the repercussions of the use of cannabis on the quality of life of patients, relating the role of the pharmacist in this trajectory. For this, an integrative literature review was carried out in the electronic databases PubMed, SciELO, LILACS, Science Direct, BVS and CAPES journals, using publications between 2011 and 2021 and the following terms (keywords and delimiters) and combinations of the same: Cannabis sativa, medical marijuana, Cannabis, senile dementia, dementia syndrome, Alzheimer's disease, senescence, senility, pharmaceutical care and clinical pharmaceutical, to answer the guiding questions. The sample consisted of 10 studies that showed the effectiveness of the therapy and promising results on the quality of life of the senile public, which is an auspicious choice of treatment, in addition to the importance of the pharmacist in promoting this therapy. Studies like this help to show the need to consider this treatment, which has been used for millennia by humanity, but which, today, suffers from sociocultural remnants, as its consumption is linked to recreational use. Finally, they awaken and optimize ideas for the development of new valid and reliable instruments to support therapies for dementia syndrome.